Biotech Values

[oldberkeley]

AMRN- But seriously, I follow it and almost bought in the first part of August (should have!) when price and volume surged. I think that this run-up is all predicated on the hope of positive FDA action.

If that happens, an immediate 50% or more is certainly possible. But if it doesn't, IMHO it's going straight back to the $1.30's. That's a sizable downside in my book.